87 related articles for article (PubMed ID: 33071176)
1. PNPLA3 polymorphisms are associated with raised alanine aminotransferase levels in hepatitis C virus genotype 3.
Agrawal T; Gaggar A; Subramanian M; Kottilil S; Choudhary A; Rao PN; Shah S; Trehanpati N
Arab J Gastroenterol; 2020 Dec; 21(4):267-272. PubMed ID: 33071176
[TBL] [Abstract][Full Text] [Related]
2. PNPLA3 rs738409 causes steatosis according to viral & IL28B genotypes in hepatitis C.
Ampuero J; Del Campo JA; Rojas L; García-Lozano JR; Solá R; Andrade R; Pons JA; Navarro JM; Calleja JL; Buti M; González-Escribano MF; Forns X; Diago M; García-Samaniego J; Romero-Gómez M
Ann Hepatol; 2014; 13(4):356-63. PubMed ID: 24927606
[TBL] [Abstract][Full Text] [Related]
3. Association of interleukin-28B rs12979860 and rs8099917 polymorphisms with sustained viral response in hepatitis C virus genotype 1 and 3 infected patients from the Indian subcontinent.
Ranjan P; Fletcher GJ; Radhakrishnan M; Sivakumar J; Premkumar PS; Goel A; Zachariah UG; Abraham P
Indian J Med Microbiol; 2016; 34(3):335-41. PubMed ID: 27514956
[TBL] [Abstract][Full Text] [Related]
4. Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis.
Cai T; Dufour JF; Muellhaupt B; Gerlach T; Heim M; Moradpour D; Cerny A; Malinverni R; Kaddai V; Bochud M; Negro F; Bochud PY
J Hepatol; 2011 Sep; 55(3):529-535. PubMed ID: 21236304
[TBL] [Abstract][Full Text] [Related]
5. Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study.
Mueller JL; King LY; Johnson KB; Gao T; Nephew LD; Kothari D; Simpson MA; Zheng H; Wei L; Corey KE; Misdraji J; Lee JH; Lin MV; Gogela NA; Fuchs BC; Tanabe KK; Gordon FD; Curry MP; Chung RT
Clin Transplant; 2016 Apr; 30(4):452-60. PubMed ID: 26854475
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of
Świątek-Kościelna B; Kałużna E; Strauss E; Nowak J; Bereszyńska I; Gowin E; Wysocki J; Rembowska J; Barcińska D; Mozer-Lisewska I; Januszkiewicz-Lewandowska D
World J Gastroenterol; 2017 Jun; 23(21):3815-3824. PubMed ID: 28638221
[TBL] [Abstract][Full Text] [Related]
7. Genetic Polymorphisms of IL28B and PNPLA3 Are Predictive for HCV Related Rapid Fibrosis Progression and Identify Patients Who Require Urgent Antiviral Treatment with New Regimens.
Tamaki N; Kurosaki M; Higuchi M; Takada H; Nakakuki N; Yasui Y; Suzuki S; Tsuchiya K; Nakanishi H; Itakura J; Takahashi Y; Ogawa S; Tanaka Y; Asahina Y; Izumi N
PLoS One; 2015; 10(9):e0137351. PubMed ID: 26352693
[TBL] [Abstract][Full Text] [Related]
8. The role of PNPLA3 and TM6SF2 polymorphisms on liver fibrosis and metabolic abnormalities in Brazilian patients with chronic hepatitis C.
Oliveira AIN; Malta FM; Zitelli PMY; Salles APM; Gomes-Gouvea MS; Nastri ACS; Pinho JRR; Carrilho FJ; Oliveira CP; Mendes-Corrêa MC; Pessoa MG; Mazo DF
BMC Gastroenterol; 2021 Feb; 21(1):81. PubMed ID: 33622266
[TBL] [Abstract][Full Text] [Related]
9. The rs738409 polymorphism of the PNPLA3 gene is associated with hepatic steatosis and fibrosis in Brazilian patients with chronic hepatitis C.
Manchiero C; Nunes AKDS; Magri MC; Dantas BP; Mazza CC; Barone AA; Tengan FM
BMC Infect Dis; 2017 Dec; 17(1):780. PubMed ID: 29258449
[TBL] [Abstract][Full Text] [Related]
10. Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients.
Sarrazin C; Susser S; Doehring A; Lange CM; Müller T; Schlecker C; Herrmann E; Lötsch J; Berg T
J Hepatol; 2011 Mar; 54(3):415-21. PubMed ID: 21112657
[TBL] [Abstract][Full Text] [Related]
11. The Association of PNPLA3, COX-2 and DHCR7 Polymorphisms with Advanced Liver Fibrosis in Patients with HCV Mono- Infection and HCV/HIV Co-Infection.
Kiatbumrung R; Chuaypen N; Payungporn S; Avihingsanon A; Tangkijvanich P
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2191-2197. PubMed ID: 30139224
[TBL] [Abstract][Full Text] [Related]
12. Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3.
Mandorfer M; Payer BA; Schwabl P; Steiner S; Ferlitsch A; Aichelburg MC; Stättermayer AF; Ferenci P; Obermayer-Pietsch B; Grabmeier-Pfistershammer K; Trauner M; Peck-Radosavljevic M; Reiberger T
Liver Int; 2015 Mar; 35(3):876-85. PubMed ID: 24905495
[TBL] [Abstract][Full Text] [Related]
13. IL28B genetic variation and treatment response in patients with hepatitis C virus genotype 3 infection.
Moghaddam A; Melum E; Reinton N; Ring-Larsen H; Verbaan H; Bjøro K; Dalgard O
Hepatology; 2011 Mar; 53(3):746-54. PubMed ID: 21374656
[TBL] [Abstract][Full Text] [Related]
14. The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic hepatitis C infection.
Clark PJ; Thompson AJ; Zhu Q; Vock DM; Zhu M; Patel K; Harrison SA; Naggie S; Ge D; Tillmann HL; Urban TJ; Shianna K; Fellay J; Goodman Z; Noviello S; Pedicone LD; Afdhal N; Sulkowski M; Albrecht JK; Goldstein DB; McHutchison JG; Muir AJ
Dig Dis Sci; 2012 Aug; 57(8):2213-21. PubMed ID: 22543885
[TBL] [Abstract][Full Text] [Related]
15. Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy.
Barreiro P; Pineda JA; Rallón N; Naggie S; Martín-Carbonero L; Neukam K; Rivero A; Benito JM; Caruz A; Vispo E; Camacho A; Medrano J; McHutchison J; Soriano V
J Infect Dis; 2011 Jun; 203(11):1629-36. PubMed ID: 21592993
[TBL] [Abstract][Full Text] [Related]
16. PNPLA3 rs738409 G allele carriers with genotype 1b HCV cirrhosis have lower viral load but develop liver failure at younger age.
Senkerikova R; Frankova S; Jirsa M; Kreidlova M; Merta D; Neroldova M; Chmelova K; Spicak J; Sperl J
PLoS One; 2019; 14(9):e0222609. PubMed ID: 31527889
[TBL] [Abstract][Full Text] [Related]
17. Implications of PNPLA3 polymorphism in chronic hepatitis C patients receiving peginterferon plus ribavirin.
Valenti L; Aghemo A; Stättermayer AF; Maggioni P; De Nicola S; Motta BM; Rumi MG; Dongiovanni P; Ferenci P; Colombo M; Fargion S
Aliment Pharmacol Ther; 2012 Jun; 35(12):1434-42. PubMed ID: 22530607
[TBL] [Abstract][Full Text] [Related]
18. Association of diabetes and PNPLA3 genetic variants with disease severity of patients with chronic hepatitis C virus infection.
Huang CF; Dai CY; Yeh ML; Huang CI; Tai CM; Hsieh MH; Liang PC; Lin YH; Hsieh MY; Yang HL; Huang JF; Lin ZY; Chen SC; Yu ML; Chuang WL
J Hepatol; 2015 Mar; 62(3):512-8. PubMed ID: 25457210
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-28b CC genotype predicts early treatment response and CT/TT genotypes predicts non-response in patients infected with HCV genotype 3.
Gupta AC; Trehanpati N; Sukriti S; Hissar S; Midha V; Sood A; Sarin SK
J Med Virol; 2014 Apr; 86(4):707-12. PubMed ID: 24415442
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 28B.rs12979860 genotype does not affect hepatitis C viral load in Egyptians with genotype 4 chronic infection.
Abdelwahab SF; Zakaria Z; Allam WR; Hamdy S; Mahmoud MA; Sobhy M; Rewisha E; Waked I
Arch Virol; 2015 Nov; 160(11):2833-7. PubMed ID: 26280523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
